Dr. Rudolf Widmann
Chairman of the Board
Medical Sciences
AOP Orphan Pharmaceuticals AG
Austria
Biography
Dr. Rudolf Widman achieved a long-cherished goal in establishing AOP Orphan. His interest in rare diseases dates back to his pharmacy studies at the University of Innsbruck, which he completed in 1981. He deepened his knowledge in the course of writing his dissertation and working as an assistant at the Institute for Pharmacology in Innsbruck, focusing particularly on epilepsy and affections of the central nervous system. In the years that followed, he worked at the Max Planck Institute for neurological research on cerebral infarction.
Research Interest
neurology, pharmacology
